D’Alessandro-Gabazza, Corina N.
Yasuma, Taro
Kobayashi, Tetsu
Toda, Masaaki
Abdel-Hamid, Ahmed M. http://orcid.org/0000-0002-4557-2008
Fujimoto, Hajime
Hataji, Osamu
Nakahara, Hiroki
Takeshita, Atsuro
Nishihama, Kota
Okano, Tomohito
Saiki, Haruko
Okano, Yuko
Tomaru, Atsushi
Fridman D’Alessandro, Valeria
Shiraishi, Miyako http://orcid.org/0000-0002-5782-1649
Mizoguchi, Akira
Ono, Ryoichi
Ohtsuka, Junpei
Fukumura, Masayuki
Nosaka, Tetsuya http://orcid.org/0000-0002-0037-7049
Mi, Xuenan
Shukla, Diwakar
Kataoka, Kensuke
Kondoh, Yasuhiro
Hirose, Masaki
Arai, Toru
Inoue, Yoshikazu http://orcid.org/0000-0003-3994-874X
Yano, Yutaka
Mackie, Roderick I.
Cann, Isaac http://orcid.org/0000-0003-0539-0119
Gabazza, Esteban C. http://orcid.org/0000-0001-5748-1499
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (17K08442, 18K08175)
Takeda Science Foundation (2019)
Article History
Received: 31 May 2021
Accepted: 21 February 2022
First Online: 23 March 2022
Competing interests
: E.C.G. and T.K. have a patent on the TGFβ1 TG mice used in the present study. In addition, there is an invention disclosure by C.N.D.G., E.C.G., and I.C. on the apoptotic peptides identified in this study and anticorisin mAtbs developed for the treatment of pulmonary fibrosis described in this study. None of the other authors declared any competing interests regarding the present work.